Evaluation of efficacy and safety of intralesional vitamin D3 in comparison with intralesional measles, mumps and rubella (MMR) vaccine in the treatment of multiple cutaneous warts
Vijay Deepak Joshi et al · Termedia Publishing House · 2024
Accesso alla risorsa
Apri il contenuto dall’opzione principale o scegli un’altra fonte disponibile.
Accesso aperto disponibile
Come citare
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
al, V. D. J. E. (2024). Evaluation of efficacy and safety of intralesional vitamin D3 in comparison with intralesional measles, mumps and rubella (MMR) vaccine in the treatment of multiple cutaneous warts. https://doi.org/10.5114/dr.2023.138824
MLA
al, Vijay Deepak Joshi et. "Evaluation of efficacy and safety of intralesional vitamin D3 in comparison with intralesional measles, mumps and rubella (MMR) vaccine in the treatment of multiple cutaneous warts." 2024. https://doi.org/10.5114/dr.2023.138824.
Chicago
al, Vijay Deepak Joshi et. 2024. "Evaluation of efficacy and safety of intralesional vitamin D3 in comparison with intralesional measles, mumps and rubella (MMR) vaccine in the treatment of multiple cutaneous warts.". https://doi.org/10.5114/dr.2023.138824.
Harvard
al, V. D. J. E. 2024, Evaluation of efficacy and safety of intralesional vitamin D3 in comparison with intralesional measles, mumps and rubella (MMR) vaccine in the treatment of multiple cutaneous warts, Termedia Publishing House, available at: https://doi.org/10.5114/dr.2023.138824 [Accessed 5 Aug. 2026].
Dettagli della risorsa
Informazioni bibliografiche utili per verificare che sia il materiale corretto.
- Titolo
- Evaluation of efficacy and safety of intralesional vitamin D3 in comparison with intralesional measles, mumps and rubella (MMR) vaccine in the treatment of multiple cutaneous warts
- Autore / collaboratori
- Vijay Deepak Joshi et al
- Editore
- Termedia Publishing House
- Anno di pubblicazione
- 2024
- ISSN
- 0033-2526
- ISSN
- 0033-2526
- Lingua
- Inglés
Soggetti
Esplora risorse correlate a partire da questi soggetti.